LD-2 disclosure · 1st Quarter - Report
ALKERMES, INC.
Client
- Name
- ALKERMES, INC.
- Description
- Biopharmaceutical company
- Location
- Massachusetts · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946: ORPHAN Cures Act. Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically. Provide guidance and advice regarding mental health, public health and regulatory reform.
LobbyistsALANNA TEMME · SOPHIE KHANAHMADI · MAXIMILIAN WALTER
Covered position (ALANNA TEMME): Legislative Director, U.S. Representative Jon Porter
Covered position (SOPHIE KHANAHMADI): Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS)